Expensify (NASDAQ: EXFY) insider files Rule 144 planned stock sale

Rhea-AI Filing Summary

Expensify, Inc. insider sale notice: This Form 144 reports that Carlos Alvarez Divo plans to sell up to 8,972 shares of Expensify, Inc. Class A Common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 13,507.36 and an approximate sale date of 12/30/2025. The shares to be sold were acquired via RSU vesting from Expensify, Inc. as compensation, including 2,468 shares on 12/15/2025 and 6,504 shares on 12/22/2025. The filing also lists prior sales during the past three months, including 19,568, 3,100, and 21,580 Class A Common shares sold on 11/18/2025, 11/21/2025, and 11/24/2025, respectively, with gross proceeds of 30035, 4714, and 31370.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza New York NY 10004	8972	13507.36	80840150	12/30/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	12/15/2025	RSU Vesting	Expensify, Inc.			2468	12/15/2025	Compensation
Class A Common	12/22/2025	RSU Vesting	Expensify, Inc.			6504	12/22/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carlos Alvarez Divo 88 Kearny St Ste 1600 San Francisco CA 94108	Class A Common	11/18/2025	19568	30035
Carlos Alvarez Divo 88 Kearny St Ste 1600 San Francisco CA 94108	Class A Common	11/21/2025	3100	4714
Carlos Alvarez Divo 88 Kearny St Ste 1600 San Francisco CA 94108	Class A Common	11/24/2025	21580	31370

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Expensify (EXFY) shares are covered by this Form 144 filing?

The Form 144 covers a proposed sale of up to 8,972 shares of Expensify, Inc. Class A Common stock.

What is the aggregate market value of the Expensify (EXFY) shares to be sold?

The filing reports an aggregate market value of 13,507.36 for the 8,972 Class A Common shares proposed to be sold.

When were the Expensify (EXFY) shares in this Form 144 acquired?

The shares were acquired via RSU vesting from Expensify, Inc., with 2,468 Class A Common shares vesting on 12/15/2025 and 6,504 shares vesting on 12/22/2025 as compensation.

When does the seller expect to sell the Expensify (EXFY) shares under this Form 144?

The Form 144 lists an approximate date of sale of 12/30/2025 for the 8,972 Class A Common shares on NASDAQ.

Which broker is handling the planned Expensify (EXFY) share sale?

The planned sale of 8,972 Class A Common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY 10004.

What prior Expensify (EXFY) stock sales by the same seller are disclosed?

During the past three months, the filing shows that Carlos Alvarez Divo sold Class A Common shares on three dates: 19,568 shares on 11/18/2025 for gross proceeds of 30035, 3,100 shares on 11/21/2025 for 4714, and 21,580 shares on 11/24/2025 for 31370.

What representation does the seller make about Expensify (EXFY) information in this Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about Expensify, Inc.’s current or prospective operations that has not been publicly disclosed.